Effectively Utilizing Resources Through Commitment to R&D and Enhancing Technological Capabilities for the Promotion of Health.
Genetic Modification Technology
Having introduced genetic modification technology, Denka Seiken became the first commercial producer in Japan of Norovirus(NV) antibodies, and developed in vitro diagnostic tests. In the production of useful components of viruses, bacteria, and other microorganisms, as well as for in vitro diagnostics.
Immune Sera Reaction Technology
Immune sera reaction technology using reactions to antigens and antibodies is a highly sensitive method of analyzing biological samples. Due to possessing knowledge and experience in this area, which surpasses other Japanese companies, Denka Seiken has managed to develop a large number of excellent in vitro diagnostic reagents. In recent years, we combined these technologies with automation and simple measerement technology in order to commercialize distinctive products, which have been praised highly in many fields and industries.
Monoclonal Antibody Development Technology
Denka Seiken develops and produces various kinds of monoclonal antibodies for bacteria and other microorganisms, and for biological samples. Our in-house produced monoclonal antibodies are widely used in the development of in vitro diagnostic reagents,etc.
Sterile Pharmaceutical Manufacturing Technology
In the development and production of vaccines, sterile pharmaceutical manufacturing technology is needed in order to meet the very strict standards. After more then half a century of developing and producing vaccines, Denka Seiken uses advanced sterile handling technology built on its abundant experience, and produces excellent quality vaccines.
Culturing Technology
Since its foundation, Denka Seiken has established technologies for the culture of numerous bacteria, viruses, and other microorganisms, as well as for tissue culture. We have made maximum use of our advanced technologies in the development of vaccines, in vitro diagnostic reagents, and similar products. We will continue to strive for further advancement and progress in the future, with microbial culture technology positioned as one of our core technologies.